Dr. Reddy’s Laboratories Ltd ADR Capital Reinvestment Ratio
Dr. Reddy’s Laboratories Ltd ADR capital reinvestment ratio. Dr. Reddy’s Laboratories Ltd ADR (RDY) has a Capital Reinvestment Ratio of 0.67x as of December 2025, meaning it reinvests 1% of its operating cash flow ($10.91 Billion) in capital expenditures ($7.32 Billion). See Dr. Reddy’s Laboratories Ltd ADR free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Dr. Reddy’s Laboratories Ltd ADR (2000–2025)
Capital reinvestment ratio of Dr. Reddy’s Laboratories Ltd ADR from 2000 to 2025. This chart tracks Dr. Reddy’s Laboratories Ltd ADR's Capital Reinvestment Ratio across 26 annual periods. See RDY free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
Dr. Reddy’s Laboratories Ltd ADR Capital Reinvestment Ratio by Year (2000–2025)
Dr. Reddy’s Laboratories Ltd ADR capital reinvestment ratio by year from 2000 to 2025. For the full cash flow conversion analysis, see Dr. Reddy’s Laboratories Ltd ADR (RDY) cash flow conversion.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.74x | $46.43 Billion | $34.40 Billion | ▲ +22.7% |
| 2024 | 0.60x | $45.43 Billion | $27.43 Billion | ▲ +88.5% |
| 2023 | 0.32x | $58.87 Billion | $18.86 Billion | ▼ -52.7% |
| 2022 | 0.68x | $28.11 Billion | $19.05 Billion | ▲ +92.6% |
| 2021 | 0.35x | $35.70 Billion | $12.56 Billion | ▲ +71.7% |
| 2020 | 0.20x | $29.84 Billion | $6.12 Billion | ▼ -21.5% |
| 2019 | 0.26x | $28.70 Billion | $7.49 Billion | ▼ -57.4% |
| 2018 | 0.61x | $18.03 Billion | $11.04 Billion | ▼ -67.8% |
| 2017 | 1.91x | $21.51 Billion | $40.98 Billion | ▲ +428.3% |
| 2016 | 0.36x | $41.25 Billion | $14.88 Billion | ▼ -41.1% |
| 2015 | 0.61x | $25.03 Billion | $15.33 Billion | ▲ +12.1% |
| 2014 | 0.55x | $19.46 Billion | $10.63 Billion | ▼ -0.9% |
| 2013 | 0.55x | $13.32 Billion | $7.34 Billion | ▲ +3.6% |
| 2012 | 0.53x | $16.15 Billion | $8.59 Billion | ▼ -63.3% |
| 2011 | 1.45x | $8.01 Billion | $11.61 Billion | ▲ +347.5% |
| 2010 | 0.32x | $13.23 Billion | $4.28 Billion | ▼ -69.4% |
| 2009 | 1.06x | $4.50 Billion | $4.76 Billion | ▼ -4.4% |
| 2008 | 1.11x | $6.12 Billion | $6.77 Billion | ▲ +175.6% |
| 2007 | 0.40x | $11.83 Billion | $4.75 Billion | ▼ -65.6% |
| 2006 | 1.17x | $1.65 Billion | $1.92 Billion | ▲ +52.7% |
| 2005 | 0.76x | $2.29 Billion | $1.75 Billion | ▲ +26.4% |
| 2004 | 0.60x | $4.01 Billion | $2.42 Billion | ▲ +74.0% |
| 2003 | 0.35x | $4.35 Billion | $1.51 Billion | ▲ +48.1% |
| 2002 | 0.23x | $4.65 Billion | $1.09 Billion | ▼ -70.4% |
| 2001 | 0.79x | $614.87 Million | $487.20 Million | ▲ +97.8% |
| 2000 | 0.40x | $14.29 Million | $5.73 Million | — |